Thierry Ng – NCARD

Western Australia advances RNA cancer therapeutics: NCARD at the forefront

September 2, 2024

Western Australia has reinforced its leadership in RNA technology with the recent launch of the Australian Centre for RNA Therapeutics in Cancer (ACRTC). Supported by over $6 million in funding…

Don’t miss the 2024 NCARD Public Lecture!

August 23, 2024

Event

The 2024 NCARD Public Lecture: “Asbestos: New Frontiers in Management, Science, and Care” will be held on September 18. We have three speakers for the evening to discuss the latest…

Celebrating Excellence: Nicola Principe Honoured as Student Scientist of the Year

August 21, 2024

News

The National Centre for Asbestos Related Diseases (NCARD) is thrilled to announce that Nicola Principe has been named Student Scientist of the Year at the 2024 Premier’s Science Awards. This…

Breakthrough research giving new hope for treatment of dust diseases

August 6, 2024

News

Through icare, the Dust Diseases Board has funded Dr Alistair Cook’s research over three years endeavouring to create better outcomes for patients who are diagnosed with mesothelioma. Dr Cook was…

NCARD celebrates Nicola Principe’s Premier’s Science Award finalist nomination

July 30, 2024

News

The National Centre for Asbestos Related Diseases (NCARD) proudly announces that PhD candidate Nicola Principe has been selected as a finalist for the Premier’s Science Awards 2024 in the Student…

2023 Annual Report

July 29, 2024

Annual Reports, News

We are excited to announce the release of the National Centre for Asbestos Related Diseases (NCARD) 2023 Annual Report. This document showcases our team’s remarkable achievements and unwavering efforts in…

Sir Charles Gairdner Hospital researchers awarded WA FHRI Grant to establish cutting-edge pleural research centre

July 19, 2024

News

The newly funded, “Collaborative Centre for Innovative Pleural Research”, led by Professor Y C Gary Lee based at Sir Charles Gairdner Hospital, Institute for Respiratory Health and The University of…

Genetically engineered MexTAg mice advance understanding of asbestos-related cancer

May 24, 2024

News

At the National Centre of Asbestos Related Diseases (NCARD), we have produced many cutting-edge preclinical tools and models to support our research. These efforts are largely focused on the rare…

Welcoming Thierry Ng, NCARD’s new Project Officer

May 6, 2024

News

Hello everyone! I’m Thierry, and I’m thrilled to join NCARD as the new Project Officer. My arrival at NCARD is the result of an irregular and winding journey that started…

Copper-Binding Drugs: A New Approach to Mesothelioma Therapy

April 29, 2024

News

The National Centre for Asbestos Related Diseases (NCARD) proudly announces that one of its projects has been awarded funding through the 2024 Cancer Council WA Research Project Grant scheme. This…

Western Australia advances RNA cancer therapeutics: NCARD at the forefront

Don’t miss the 2024 NCARD Public Lecture!

Celebrating Excellence: Nicola Principe Honoured as Student Scientist of the Year

Breakthrough research giving new hope for treatment of dust diseases

NCARD celebrates Nicola Principe’s Premier’s Science Award finalist nomination

2023 Annual Report

Sir Charles Gairdner Hospital researchers awarded WA FHRI Grant to establish cutting-edge pleural research centre

Genetically engineered MexTAg mice advance understanding of asbestos-related cancer

Welcoming Thierry Ng, NCARD’s new Project Officer

Copper-Binding Drugs: A New Approach to Mesothelioma Therapy

National Centre for Asbestos Related Diseases

Latest News

Recent Posts

Scientific Publications

Subscribe

Contacts